DNA/Gene Microarray Market is estimated to account for US$ 3,018.3 Mn in terms of value in 2020 and is expected to reach US$ 7,693.0 Mn by the end of 2027

"Coherent Market Insights announced that it’s published an exclusive report namely Global DNA/Gene Microarray Market by Manufacturers, Regions, Type, and Application, Forecast to 2027 in its research database with report summary, table of content, research methodologies, and data sources. The research study offers a substantial knowledge platform for entrants and investors as well as veteran companies, manufacturers functioning in the Worldwide DNA/Gene Microarray Market. This is an informative study covering the market with an in-depth analysis and portraying the current state of affairs in the industry."

Get Latest Insights in Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/3825

The human DNA or Gene Microarray technology is used to study and profile the effects of genetic diseases on various organs, tissues, and organs of the body such as the cardiovascular, immune, and metabolic systems. The availability of various DNA or Gene Microarray tests has meant that patients with certain types of diseases, like type I diabetes, heart disease, multiple sclerosis, Parkinson's disease, and more can now accurately and quickly test for their specific diseases by analyzing their DNA or Gene Microarray results with the help of their doctors and physicians.

In December 2018, Illumina, Inc. announced the launch of its new high-density genotyping array, the Infinium™ Global Diversity Array to accelerate human disease research and improve health.

In April 2020, Sengenics, announced the launch of a new KREX™-based array, the ImmuKyne™ protein array, to improve and accelerate effective response for COVID-19 by understanding whether autoantibodies play a role in progression to severe disease in COVID-19 patients

The increasing prevalence of cancer around the globe is a prime factor fueling the growth of DNA/Gene microarray market. According to the World Health Organization, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. Around 70% of deaths from cancer occur in low- and middle-income countries. Moreover, the growing popularity of advanced medical genetics across the health care sector is another major factor propelling growth of DNA/Gene microarray market. Furthermore, increasing global healthcare spending is further anticipated to foster the market growth of the array.

Additionally, expansion of the pharmaceutical and biotechnology sector owing to growing spending is also major factor stimulating market growth over the forecast period. According to the report from IQVIA Institute, the global market for pharmaceuticals reached $1.2 trillion in 2018, up to $100 billion from 2017,

On the other hand, lack of technically trained resources and availability of other substitutes such as bio-analytical instruments and screening are projected to restrict the market growth of the array.

From the geographical point of view, North America is expected to dominate the global DNA/Gene microarray market and this is attributed to increasing demand for personalized medicine. For instance, in February 2020, the FDA approved or cleared 12 personalized medicines and seven diagnostics in 2019, helping providers address the root causes of disease and further integrating precision medicine with clinical care. Also, the presence of well-established health care infrastructure in the region is further expected to fuel the regional market growth of array.

Major Players Are Operating In The Market: Affymetrix, Inc., Illumina, Inc., Agilent Technologies Inc., Roche NimbleGen Inc., Sequenom, Inc., Biometrix Technology Inc., LC Sciences, Life Technologies Corp., Lifegen Technologies LLC, Microarrays Inc..

Buy This Research Study Report (Flat US $2000 OFF) @ https://www.coherentmarketinsights.com/promo/buynow/3825

Contact Us

Name: Mr. Shah
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.